Indication
Mycobacterium Avium Complex-lung Disease (MAC-LD)
1 clinical trial
5 products
Clinical trial
A Phase 2/3, Multicenter, Randomized, Open-label, Active-controlled Study to Evaluate the Efficacy and Safety of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Status: Recruiting, Estimated PCD: 2025-09-23
Product
BedaquilineProduct
ClarithromycinProduct
EthambutolProduct
RifampicinProduct
Rifabutin